Flexible RTSM Enables Mid-Study Switch to Direct-to-Patient Dispensation in Immunology Trial
See how SmartSignals RTSM enabled a global phase 2 immunology study to transition from in-clinic dosing to a direct-to-patient clinical supplies...
See how SmartSignals RTSM enabled a global phase 2 immunology study to transition from in-clinic dosing to a direct-to-patient clinical supplies...
Explore patient engagement strategies that supported study participants during the COVID-19 pandemic, and evolving solutions for clinical research.
Read the EMA’s recommendations for decentralized elements in clinical trials. Learn how they support flexibility, patient access, and data collection.